Molina Healthcare (MOH) Projected to Post Quarterly Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is projected to release its Q2 2025 earnings data after the market closes on Wednesday, July 23rd. Analysts expect Molina Healthcare to post earnings of $6.12 per share and revenue of $10.94 billion for the quarter. Molina Healthcare has set its FY 2025 guidance at 24.500- EPS.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating analysts’ consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The business had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the firm earned $5.73 EPS. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $28 EPS for the next fiscal year.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $214.35 on Wednesday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.87. Molina Healthcare has a fifty-two week low of $213.22 and a fifty-two week high of $365.23. The firm has a 50-day simple moving average of $289.21 and a 200 day simple moving average of $302.23. The company has a market cap of $11.62 billion, a PE ratio of 10.35, a P/E/G ratio of 0.92 and a beta of 0.55.

Analysts Set New Price Targets

A number of brokerages recently weighed in on MOH. Sanford C. Bernstein began coverage on shares of Molina Healthcare in a research report on Tuesday, April 22nd. They set an “outperform” rating and a $414.00 price objective for the company. Morgan Stanley cut shares of Molina Healthcare from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $364.00 to $266.00 in a research report on Thursday, July 10th. Mizuho set a $330.00 target price on shares of Molina Healthcare and gave the stock an “outperform” rating in a research report on Friday, July 11th. Truist Financial upped their target price on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Finally, Robert W. Baird restated a “neutral” rating and issued a $375.00 target price (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $352.21.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director directly owned 11,244 shares of the company’s stock, valued at $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer directly owned 257,715 shares of the company’s stock, valued at approximately $82,484,262.90. This represents a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.26% of the stock is owned by corporate insiders.

Institutional Trading of Molina Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Baird Financial Group Inc. acquired a new stake in Molina Healthcare during the first quarter valued at approximately $210,000. NewEdge Advisors LLC lifted its stake in Molina Healthcare by 33.4% during the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock valued at $364,000 after purchasing an additional 277 shares during the last quarter. Jones Financial Companies Lllp lifted its position in shares of Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock valued at $544,000 after acquiring an additional 1,448 shares in the last quarter. Focus Partners Wealth lifted its position in shares of Molina Healthcare by 82.7% in the 1st quarter. Focus Partners Wealth now owns 3,749 shares of the company’s stock valued at $1,235,000 after acquiring an additional 1,697 shares in the last quarter. Finally, Woodline Partners LP purchased a new stake in shares of Molina Healthcare in the 1st quarter valued at approximately $1,541,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.